Publications by authors named "Helen Tuvesson"

Claim this Profile
A
An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod.
Roger Hesselstrand, Jörg H W Distler, Gabriela Riemekasten, Dirk M Wuttge, Marie Törngren, Helén Tuvesson

Arthritis Res Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Andrew J Armstrong, Aseem Anand, Lars Edenbrandt, Eva Bondesson, Anders Bjartell, Helen Tuvesson

JAMA Oncol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer.
Cora Sternberg, Andrew Armstrong, Roberto Pili, Siobhan Ng, Robert Huddart, Helen Tuvesson

J Clin Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.
Martin Stenström, Helén Carlsson Nyhlén, Marie Törngren, David Liberg, Birgitta Sparre, Helén Tuvesson

J Dermatol Sci· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging study in patients with systemic lupus erythematosus.
Anders A Bengtsson, Gunnar Sturfelt, Christian Lood, Lars Rönnblom, Ronald F van Vollenhoven, Helén Tuvesson

Arthritis Rheum· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased degradation rate of nitrososureas in media containing carbonate.
Janeric Seidegård, Lena Grönquist, Helen Tuvesson, Per-Olov Gunnarsson

In Vitro Cell Dev Biol Anim· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
Helén Tuvesson, Ingrid Hallin, Robert Persson, Birgitta Sparre, Per Olov Gunnarsson

Drug Metab Dispos· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis